HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 96 filers reported holding HARVARD BIOSCIENCE INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,207,818 | -16.1% | 2,141,353 | +7.1% | 10.12% | -19.4% |
| Q2 2023 | $10,980,000 | +27.3% | 2,000,000 | -2.6% | 12.55% | +27.0% |
| Q1 2023 | $8,626,409 | +38.2% | 2,053,907 | -8.9% | 9.88% | +6.7% |
| Q4 2022 | $6,243,322 | +50.5% | 2,253,907 | +39.1% | 9.26% | +47.9% |
| Q3 2022 | $4,149,000 | -7.8% | 1,620,783 | +29.7% | 6.26% | -19.3% |
| Q2 2022 | $4,500,000 | -6.7% | 1,250,000 | +61.0% | 7.76% | +55.3% |
| Q1 2022 | $4,821,000 | -14.5% | 776,253 | -3.0% | 5.00% | -36.2% |
| Q4 2021 | $5,640,000 | – | 800,000 | – | 7.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harvey Partners, LLC | 1,020,036 | $7,120,000 | 5.32% |
| Portolan Capital Management | 2,358,010 | $16,459,000 | 1.20% |
| Acuitas Investments, LLC | 375,836 | $2,623,000 | 1.14% |
| Parkman Healthcare Partners LLC | 475,367 | $3,318,000 | 0.84% |
| Adirondack Research & Management Inc. | 90,020 | $628,000 | 0.76% |
| Archon Capital Management LLC | 736,236 | $5,139,000 | 0.73% |
| BARD ASSOCIATES INC | 294,697 | $2,057,000 | 0.70% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,621,775 | $11,320,000 | 0.65% |
| GLOBEFLEX CAPITAL L P | 268,466 | $1,874,000 | 0.41% |
| Monarch Partners Asset Management LLC | 330,083 | $2,304,000 | 0.34% |